Adam Baumgart

Adam is Global Head of Quality, Training and Risk Management at AstraZeneca. He has spent 30 years in Clinical Research and was until end of 2018, with Covance for 11 years. He was instrumental in developing Covance’s RBM processes and roles and Xcellerate® Monitoring and Data Management technology offerings.
Adam started his career in data management / clinical operations with Wyeth and Glaxo and then moved into the vendor sector with roles of increasing responsibility with technology vendors and contract research organizations. Adam is experienced in risk-based monitoring & central monitoring, Six Sigma & LEAN, project management, clinical data management and clinical monitoring.
Adam is passionate about the opportunity risk management, risk-based monitoring and centralised monitoring capabilities bring to the way we work, to our roles and the improvements they offer in data integrity, patient safety and regulatory compliance.